Skip to main content
SpringerLink
Log in

Although torcetrapib/atorvastatin appears to be effective for hypercholesterolaemia, it may be associated with increases in BP

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pfizer.Pfizer Updates Preliminary Results of Torcetrapib/Atorvastatin Clinical Trials as Abstract for Phase 3 Study is Released. Media Release: 31 Oct 2006. Available from: URL: http://www.pfizer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Although torcetrapib/atorvastatin appears to be effective for hypercholesterolaemia, it may be associated with increases in BP. React. Wkly. 1128, 5 (2006). https://doi.org/10.2165/00128415-200611280-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611280-00015

Keywords

Search

Navigation